SanatelaTM Matrix is an advanced biomaterial tissue that promises to profoundly improve the screening of new and existing treatments against deadly cancer stem cells. The product revolutionizes the way cancer treatments are developed and targeted for individual patients.
To help fund the staffing and infrastructure needed to produce the Matrix cancer screening kits at scale and complete the on-going trials, Sanatela has kicked off a crowdfunding campaign on Indiegogo to raise $500,000. Proceeds will be used to fund two clinical studies and quickly expand production capacity to get the Sanatela Matrix into the hands of research oncologists, cancer researchers, and drug discovery firms in the U.S. and around the world.
.The Matrix, a natural 3D biological tissue which resembles gauze, is made from a material in human umbilical cords called Wharton’s Jelly, which is decellularized and bioengineered to attract and isolate cancer cells from a patient’s blood sample.
Once in the Matrix, doctors can safely test a range of cancer treatments in the lab and identify the ones that are fully effective in treating, and hopefully curing, leukemia patients.
“As an oncologist who makes treatment decisions every day, the ability to test all the therapies and options and create a treatment plan in the lab – before I administer it to my patient – will be a major improvement,” says Dr. Aljitawi.
“Oncologists already have a number of readily available therapies to treat most cancers,” says Sanatela Founder and Professor Michael Crowley, “but the challenge has always been to figure out which of the many treatment options will potentially not only target, but will also kill all of the cancer stem cells. Our new Matrix product takes the guesswork out of it.”
Sanatela has moved into a 2,000 square foot clean room space in Fairport, NY and is ramping up production of the Sanatela Matrix